Skip to content

RASAYANA IN PREGNANCY

ROLE OF MADHURAUSHADHA SIDDHA AVALEHA AS GARBHINI RASAYANA IN THE 6th AND 7th MONTH OF PREGNANCY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/10/007373
Enrollment
30
Registered
2016-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Iron and calcium supplements: GROUP B : 15 patients Calcium carbonate 500mg and Ferrous sulphate 200mg (containing 60 mg of elemental iron) are given daily once. Control Intervention1:

Sponsors

SDM AYURVEDA COLLEGE AND HOSPITAL KUTHPADY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both Primi and Multi gravida will be included. Subjects in their 20-24 weeks of pregnancy are selected. Subjects having Hb% between 8-11 Grams

Exclusion criteria

Exclusion criteria: Pregnancy complicated with intra uterine growth retardation, p/v bleeding, abruptio placenta, placenta previa, pre-eclampsia, oligo/polyhydraminos, multiple pregnancy, gestational diabetes, sickle cell anaemia, thalassaemia, co-existing fibroids. Mal-absorptive diseases like chronic diarrhoea, dysentery, worm infestations. Systemic diseases like hypertension, diabetes mellitus, human immuno deficiency virus infection, cardio vascular disorders, thyroid dysfunction, hepatitis B etc.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Madhuraushadha siddha avaleha as rasayana in pregnant lady and in the infantTimepoint: 2 months of drug administration

Secondary

MeasureTime frame
efficacy of Madhuraushadha siddha avaleha on fetal and maternal immune systemTimepoint: maternal immunity at end of 7th month fetal immunity during delivery by cord blood analysis

Countries

India

Contacts

Public ContactMAMATHA KV

SDM AYURVEDA COLLEGE AND HOSPITAL KUTHPADY

mamath2@gmail.com9448215605

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026